Submitted by Anonymous (not verified) on 1 August 2023 - 7:30
Human medicines European public assessment report (EPAR): Bydureon, exenatide, Diabetes Mellitus, Type 2, Date of authorisation: 17/06/2011, Revision: 25, Status: Authorised
Source: